Sort   by:  
 Page size 
TranscriptomicsComparison of coding RNA expression of blood eosinophils from mepolizumab- or omalizumab-treated severe asthmatic patients and from healthy controls
RNA-seq comparison of coding RNA expression in blood eosinophils from patients with severe allergic eosinophilic asthma treated with mepolizumab with those of healthy controls and matched severe asthmatic patients receiving omalizumab.
ORGANISM(S): Homo sapiens 
2021-12-17 | E-MTAB-10190 | biostudies-arrayexpress
UnknownPrognostic Factors in Severe Eosinophilic Asthma in a Pediatric Population: A Prospective Cohort Study in Spain.
Not available
S-EPMC11642421 | biostudies-literature
UnknownStatistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability.
Not available
S-EPMC4109965 | biostudies-literature
UnknownMepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme.
Not available
S-EPMC7315004 | biostudies-literature
UnknownSafety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab.
Not available
S-EPMC7165132 | biostudies-literature
UnknownAbility of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
Not available
S-EPMC7004419 | biostudies-literature
UnknownChanges in Type 2 Biomarkers After Anti-IL5 Treatment in Patients With Severe Eosinophilic Asthma.
Not available
S-EPMC7840863 | biostudies-literature
GenomicsTranscriptomic profiling of inflammatory phenotypes of severe asthma using endobronchial biopsies
Transcriptomic profiling of inflammatory phenotypes of severe asthma using endobronchial biopsies
PRJNA599951 | ENA
GenomicsTargeting the IL-5 pathway in severe asthma
Targeting the IL-5 pathway in severe asthma
PRJNA1096336 | ENA
TranscriptomicsTranscriptomic profiling of inflammatory phenotypes of severe asthma using endobronchial biopsies
Severe asthma is a complex disease with different inflammatory phenotypes. Transcriptomic profiling has contributed to understanding the pathogenesis of asthma, especially type-2 inflammation; however, there is still poor understanding of non-eosinophilic asthma, and consequently there are limited t...
ORGANISM(S): Homo sapiens 
2021-07-31 | GSE143303 | GEO
Sort   by:  
 Page size